This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Clercq, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Clercq, E.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, April 2001, p. 382-397, Vol. 14, No. 2
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.2.382-397.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections

Erik De Clercq*

Division of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, K.U. Leuven, B-3000 Leuven, Belgium

Poxviruses continue to pose a major threat to human health. Monkeypox is endemic in central Africa, and the discontinuation of the vaccination (with vaccinia virus) has rendered most humans vulnerable to variola virus, the etiologic agent of smallpox, should this virus be used in biological warfare or terrorism. However, a large variety of compounds have been described that are potent inhibitors of vaccinia virus replication and could be expected to be active against other poxviruses as well. These compounds could be grouped in different classes: (i) IMP dehydrogenase inhibitors (e.g., EICAR); (ii) SAH hydrolase inhibitors (e.g., 5'-noraristeromycin, 3-deazaneplanocin A, and various neplanocin A derivatives); (iii) OMP decarboxylase inhibitors (e.g., pyrazofurin) and CTP synthetase inhibitors (e.g., cyclopentenyl cytosine); (iv) thymidylate synthase inhibitors (e.g., 5-substituted 2'-deoxyuridines); (v) nucleoside analogues that are targeted at viral DNA synthesis (e.g., Ara-A); (vi) acyclic nucleoside phosphonates [e.g., (S)-HPMPA and (S)-HPMPC (cidofovir)]; and (vii) polyanionic substances (e.g., polyacrylic acid). All these compounds could be considered potential candidate drugs for the therapy and prophylaxis of poxvirus infections at large. Some of these compounds, in particular polyacrylic acid and cidofovir, were found to generate, on single-dose administration, a long-lasting protective efficacy against vaccinia virus infection in vivo. Cidofovir, which has been approved for the treatment of cytomegalovirus retinitis in immunocompromised patients, was also found to protect mice, again when given as a single dose, against a lethal aerosolized or intranasal cowpox virus challenge. In a biological warfare scenario, it would be advantageous to be able to use a single treatment for an individual exposed to an aerosolized poxvirus. Cidofovir thus holds great promise for treating human smallpox, monkeypox, and other poxvirus infections. Anecdotal experience points to the efficacy of cidofovir in the treatment of the poxvirus infections molluscum contagiosum and orf (ecthyma contagiosum) in immunosuppressed patients.

* Mailing address: Division of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: 32-16-33.73.41. Fax: 32-16-33.73.40. E-mail: erik.declercq{at}rega.kuleuven.ac.be.

Clinical Microbiology Reviews, April 2001, p. 382-397, Vol. 14, No. 2
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.2.382-397.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kern, E. R., Prichard, M. N., Quenelle, D. C., Keith, K. A., Tiwari, K. N., Maddry, J. A., Secrist, J. A. III (2009). Activities of Certain 5-Substituted 4'-Thiopyrimidine Nucleosides against Orthopoxvirus Infections. Antimicrob. Agents Chemother. 53: 572-579 [Abstract] [Full Text]  
  • Ahmed, C. M., Dabelic, R., Waiboci, L. W., Jager, L. D., Heron, L. L., Johnson, H. M. (2009). SOCS-1 Mimetics Protect Mice against Lethal Poxvirus Infection: Identification of a Novel Endogenous Antiviral System. J. Virol. 83: 1402-1415 [Abstract] [Full Text]  
  • McSharry, J. J., Deziel, M. R., Zager, K., Weng, Q., Drusano, G. L. (2009). Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System. Antimicrob. Agents Chemother. 53: 129-135 [Abstract] [Full Text]  
  • Gammon, D. B., Snoeck, R., Fiten, P., Krecmerova, M., Holy, A., De Clercq, E., Opdenakker, G., Evans, D. H., Andrei, G. (2008). Mechanism of Antiviral Drug Resistance of Vaccinia Virus: Identification of Residues in the Viral DNA Polymerase Conferring Differential Resistance to Antipoxvirus Drugs. J. Virol. 82: 12520-12534 [Abstract] [Full Text]  
  • Caillat, C., Topalis, D., Agrofoglio, L. A., Pochet, S., Balzarini, J., Deville-Bonne, D., Meyer, P. (2008). Crystal structure of poxvirus thymidylate kinase: An unexpected dimerization has implications for antiviral therapy. Proc. Natl. Acad. Sci. USA 105: 16900-16905 [Abstract] [Full Text]  
  • Lunn, F. A., MacDonnell, J. E., Bearne, S. L. (2008). Structural Requirements for the Activation of Escherichia coli CTP Synthase by the Allosteric Effector GTP Are Stringent, but Requirements for Inhibition Are Lax. J. Biol. Chem. 283: 2010-2020 [Abstract] [Full Text]  
  • Quenelle, D. C., Collins, D. J., Herrod, B. P., Keith, K. A., Trahan, J., Beadle, J. R., Hostetler, K. Y., Kern, E. R. (2007). Effect of Oral Treatment with Hexadecyloxypropyl-[(S)-9-(3-Hydroxy-2- Phosphonylmethoxypropyl)Adenine] [(S)-HPMPA] or Octadecyloxyethyl-(S)-HPMPA on Cowpox or Vaccinia Virus Infections in Mice. Antimicrob. Agents Chemother. 51: 3940-3947 [Abstract] [Full Text]  
  • Myskiw, C., Deschambault, Y., Jefferies, K., He, R., Cao, J. (2007). Aurintricarboxylic Acid Inhibits the Early Stage of Vaccinia Virus Replication by Targeting both Cellular and Viral Factors. J. Virol. 81: 3027-3032 [Abstract] [Full Text]  
  • Pereira, L., Todorova, M, Cai, X, Makaroff, C., Emery, R., Moffatt, B. (2007). Methyl recycling activities are co-ordinately regulated during plant development. J Exp Bot 58: 1083-1098 [Abstract] [Full Text]  
  • Law, M., Carter, G. C., Roberts, K. L., Hollinshead, M., Smith, G. L. (2006). From the Cover: Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. USA 103: 5989-5994 [Abstract] [Full Text]  
  • Prichard, M. N., Keith, K. A., Quenelle, D. C., Kern, E. R. (2006). Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections.. Antimicrob. Agents Chemother. 50: 1336-1341 [Abstract] [Full Text]  
  • Neyts, J., Leyssen, P., Verbeken, E., De Clercq, E. (2004). Efficacy of Cidofovir in a Murine Model of Disseminated Progressive Vaccinia. Antimicrob. Agents Chemother. 48: 2267-2273 [Abstract] [Full Text]  
  • De Clercq, E. (2003). Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections. Clin. Microbiol. Rev. 16: 569-596 [Abstract] [Full Text]  
  • Quenelle, D. C., Collins, D. J., Kern, E. R. (2003). Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in Mice. Antimicrob. Agents Chemother. 47: 3275-3280 [Abstract] [Full Text]  
  • Keith, K. A., Hitchcock, M. J. M., Lee, W. A., Holy, A., Kern, E. R. (2003). Evaluation of Nucleoside Phosphonates and Their Analogs and Prodrugs for Inhibition of Orthopoxvirus Replication. Antimicrob. Agents Chemother. 47: 2193-2198 [Abstract] [Full Text]  
  • Saha, N., Shuman, S., Schwer, B. (2003). Yeast-Based Genetic System for Functional Analysis of Poxvirus mRNA Cap Methyltransferase. J. Virol. 77: 7300-7307 [Abstract] [Full Text]  
  • Letai, A. G., Snyder, K. M., Fett, J. D., Worthington, M. G., Ross, J. J., Neff, J. M., Lane, J. M., Fulginiti, V. A., Milton, D. K., Bozzette, S. A., Boer, R., Mack, T., Sepkowitz, K. A. (2003). Smallpox and Smallpox Vaccination. NEJM 348: 1920-1925 [Full Text]  
  • Snoeck, R., Holy, A., Dewolf-Peeters, C., Van Den Oord, J., De Clercq, E., Andrei, G. (2002). Antivaccinia Activities of Acyclic Nucleoside Phosphonate Derivatives in Epithelial Cells and Organotypic Cultures. Antimicrob. Agents Chemother. 46: 3356-3361 [Abstract] [Full Text]  
  • Neyts, J., Verbeken, E., De Clercq, E. (2002). Effect of 5-Iodo-2'-Deoxyuridine on Vaccinia Virus (Orthopoxvirus) Infections in Mice. Antimicrob. Agents Chemother. 46: 2842-2847 [Abstract] [Full Text]  
  • Kern, E. R., Hartline, C., Harden, E., Keith, K., Rodriguez, N., Beadle, J. R., Hostetler, K. Y. (2002). Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir. Antimicrob. Agents Chemother. 46: 991-995 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»